{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:33:49Z","timestamp":1790804029853,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Serum autoantibodies targeting the SSA\/Ro proteins are a key component of the classification criteria for the diagnosis of Sj\u00f6gren\u2019s syndrome (SS). Most patients' serum reacts with both Ro60 and Ro52 proteins. Here we compare the molecular and clinical characteristics of patients diagnosed with SS with anti-Ro52 in the presence or absence of anti-Ro60\/La autoantibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional study was performed. Patients in the SS biobank at Westmead Hospital (Sydney, Australia) that were positive for anti-Ro52 were included and stratified based on the absence (isolated) or presence (combined) of anti-Ro60\/La, measured by line immunoassay. We examined clinical associations and the serological and molecular characteristics of anti-Ro52 using ELISA and mass spectrometry in serological groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 123 SS patients were included for study. SS patients with isolated anti-Ro52 (12%) identified a severe serological subset characterised by higher disease activity, vasculitis, pulmonary involvement, rheumatoid factor (RhF) and cryoglobulinaemia. Serum antibodies reacting with Ro52 in the isolated anti-Ro52 subset displayed less isotype switching, less immunoglobulin variable region subfamily usage and a lower degree of somatic hypermutation than the combined anti-Ro52 subset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our cohort of SS patients, isolated anti-Ro52 represents a severe subset of SS, and is associated with the presence of cryoglobulinaemia. We therefore provide clinical relevance to the stratification of SS patients by their sero-reactivities. It is possible that the autoantibody patterns may be immunological epiphenomena of the underlying disease process, and further work is required to unearth the mechanisms of the differential clinical phenotypes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1115548","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T07:07:01Z","timestamp":1678950421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Isolated anti-Ro52 identifies a severe subset of Sj\u00f6gren\u2019s syndrome patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Adrian Y. S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trishni","family":"Putty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Suan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Chataway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier M.","family":"Thurlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne H.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25011","article-title":"The phases and natural history of Sj\u00f6gren\u2019s disease: A new model for an old disease","author":"Lee","year":"","journal-title":"Arthritis Care Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: A revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102724","article-title":"Anti-Ro60 and anti-Ro52\/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases","volume":"124","author":"Lee","year":"2021","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24597","article-title":"Antibodies to both Ro52 and Ro60 may identify Sj\u00f6gren\u2019s syndrome patients best suited for clinical trials of disease-modifying therapies","volume":"74","author":"Arma\u011fan","year":"2022","journal-title":"Arthritis Care Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874312901409010036","article-title":"Clinical characteristics and outcome of primary Sjogren\u2019s syndrome: A Large Asian Indian cohort","volume":"9","author":"Sandhya","year":"2015","journal-title":"Open Rheumatol J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00547.x","article-title":"Protein-protein interactions between native Ro52 and immunoglobulin G heavy chain","volume":"49","author":"Yang","year":"1999","journal-title":"Scand J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3718-1","article-title":"A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06299-5","article-title":"Anti-Ro52\/TRIM21 serological subsets identify differential clinical and laboratory parameters","volume":"41","author":"Lee","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203587","article-title":"Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: Undifferentiated connective tissue diseases","volume":"71","author":"Murng","year":"2018","journal-title":"J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2021.1919342","article-title":"Clinical manifestations in anti-Ro52\/SS-A antibody-seropositive patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Nakamura","year":"2021","journal-title":"Immunol Med"},{"key":"B13","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/l70874","article-title":"The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB\/La reactivities in relation to diagnosis and phenotypes in primary Sj\u00f6gren\u2019s syndrome","volume":"40","author":"Deroo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13075-017-1475-x","article-title":"Comparison of 2002 AECG and 2016 ACR\/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Le Goff","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571%","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome. A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"J Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022%","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"JRMD Open"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) is mediated by a stereotyped clonotypic antibody","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13197","article-title":"Precipitating anti-dsDNA peptide repertoires in lupus","volume":"194","author":"Wang","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/47a4kr","article-title":"Combined seronegativity in Sj\u00f6gren\u2019s syndrome","author":"Chatzis","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21956","article-title":"Pain severity and neuropathic pain symptoms in primary Sj\u00f6gren\u2019s syndrome: A comparison study of seropositive and seronegative Sj\u00f6gren\u2019s syndrome patients","volume":"65","author":"Segal","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key392%","article-title":"Is early-onset primary Sj\u00f6gren\u2019s syndrome a worse prognosis form of the disease","volume":"58","author":"Anquetil","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678920019","article-title":"Young onset of primary Sj\u00f6gren\u2019s syndrome: Clinical and immunological characteristics","volume":"7","author":"Ramos-Casals","year":"1998","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/healthcare9030363","article-title":"Diagnostic delay in patients with primary Sj\u00f6gren\u2019s syndrome: A population-based cohort study in Taiwan","volume":"9","author":"Huang","year":"2021","journal-title":"Healthc (Basel Switzerland)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2021.1887927","article-title":"Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients","volume":"50","author":"Lee","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"B26","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3076017","article-title":"Isolated Ro52 antibodies as immunological marker of a mild phenotype of undifferentiated connective tissue diseases","volume":"2017","author":"Alonso-Larruga","year":"2017","journal-title":"Int J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00504.x","article-title":"HLA class II phenotype controls diversification of the autoantibody response in primary Sj\u00f6gren\u2019s syndrome (pSS)","volume":"111","author":"Rischmueller","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.27370","article-title":"Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Reed","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/art.23377","article-title":"A b cell apotope of Ro 60 in systemic lupus erythematosus","volume":"58","author":"Reed","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.04.008","article-title":"B cell apotopes of the 60-kDa Ro\/SSA and La\/SSB autoantigens","volume":"31","author":"Reed","year":"2008","journal-title":"J Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","article-title":"Diagnostic utility of anti-Ro52 detection in systemic autoimmunity","volume":"86","author":"Dugar","year":"2010","journal-title":"Postgrad Med J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.013","article-title":"Cryoglobulinemic vasculitis in primary Sj\u00f6gren\u2019s syndrome: Clinical presentation, association with lymphoma and comparison with hepatitis c-related disease","volume":"50","author":"Argyropoulou","year":"2020","journal-title":"Semin Arthritis Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2020.01.029","article-title":"Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody","volume":"180","author":"Singh","year":"2020","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate b cells by dual engagement of IgM and toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13064","article-title":"Transforming mutations in the development of pathogenic b cell clones and autoantibodies","volume":"307","author":"Reed","year":"2022","journal-title":"Immunol Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1626","article-title":"Immune complexes present in the sera of autoimmune mice activate rheumatoid factor b cells","volume":"165","author":"Rifkin","year":"2000","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.27541","article-title":"Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and rituximab registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1115548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T07:07:05Z","timestamp":1678950425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1115548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2023.1115548"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1115548","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1115548"}}